LEADER 01379nam  2200409   450 
001 9910826648403321
005 20230808205540.0
010   $a0-309-44235-4
010   $a0-309-44233-8
035   $a(CKB)4340000000021098
035   $a(MiAaPQ)EBC4745382
035   $a(EXLCZ)994340000000021098
100   $a20161207h20162016  uy             0
101 0 $aeng
135   $aurcnu||||||||
181   $2rdacontent
182   $2rdamedia
183   $2rdacarrier
200 00$aPolicy issues in the clinical development and use of immunotherapy for cancer treatment $eproceedings of a workshop /$fErin Balogh [and three others], rapporteurs
210  1$aWashington, District of Columbia :$cThe National Academies Press,$d2016.
210  4$dİ2016
215   $a1 online resource (135 pages) $cillustrations, tables
311   $a0-309-44232-X 
320   $aIncludes bibliographical references.
606   $aCancer$xImmunotherapy$vCongresses
615  0$aCancer$xImmunotherapy
676   $a616.99406
700   $aBalogh$b Erin$01089066
702   $aBalogh$b Erin
712 02$aNational Cancer Policy Forum (U.S.),
801  0$bMiAaPQ
801  1$bMiAaPQ
801  2$bMiAaPQ
906   $aBOOK
912   $a9910826648403321
996   $aPolicy issues in the clinical development and use of immunotherapy for cancer treatment$93932989
997   $aUNINA